Hematopoiesis cells requires cells to acquire two intrinsic changes. These are the acquisition by some method of autocrine growth stimuThis account will be restricted mainly to myeloid leukemialation and a perturbation of differentiation commitment leading neoplasms that overtly involve the granulocyte-macrophage to abnormal levels of self-generation. Hematopoietic regulator subset of hematopoietic cells. To set the scene for the disaction can be involved to produce or facilitate both these changes but the same regulators can also suppress some leucussion to follow, it is necessary to summarize briefly our curkemic populations by enforced differentiation commitment.
macrophage populations. Committed granulocyte-macrophage progenitor cells are generated from multipotential stem cells and expend themselves in the production of maturing Introduction granulocytes and macrophages. As shown in Figure 1 , a large number of hematopoietic regulators have been identified as It is a particular pleasure for me to present this Memorial Lechaving some ability to regulate this process. For the generation ture. Charlotte Friend was a warm, gentle human and a loyal of progenitor cells from stem cells, stem cell factor (SCF) and colleague and friend. Jacob Furth and I in Boston were to Flk-ligand (FL) stand out as key regulators. Stem cell proliferknow her well through joint studies in 1957 and 1958 involvation requires simultaneous stimulation by two or more reguing the first use outside her laboratory of the virus that came lators and IL-3, IL-7, G-CSF, GM-CSF, IL-6 and IL-11 have all to carry her name. She later worked in my laboratory in Melbeen shown to be active partners for SCF or FL in their bourne while on a Travelling Fellowship from the Sloan-Kettstimulation of stem cell proliferation. ering Memorial Hosptial. Recognition of her accomplishments Control of the production by progenitor cells of mature grawas slow and grudging. In the mid-1950s it did not sit well nulocytes and macrophages is mediated by the four colonywith the research establishment to be a woman scientist, to stimulating factors, G-CSF, GM-CSF, M-CSF and Multi-CSF be untrained as a pathologist yet to discover a powerful leuke-(IL-3) but IL-6 and SCF are also active on granulocyte mia-inducing virus and to encounter a then unfamiliar situformation. 1 ation of viral-driven, unrestrained, hematopoietic proliferation Stimulation is essential for all cell division and the cell cycle where the affected cells only much later transform to bona times of responding cells are determined by the regulator confide transplantable leukemic cells. As we shall see, this problem remains with us today, as a vexing question in a number of leukemias. She was also one of the first workers to document that undifferentiated leukemic cells could be induced to differentiate unequivocally, in her case to maturing erythroid cells, by exposure of leukemic cell lines to chemical agents such as DMSO. This is now a familar biological phenomenon with at least certain leukemias, but not generally so, again leaving us with a continuing problem to be resolved. To break new ground in two major areas of cancer biology arouses skepticism and criticism but fortunately, in Charlotte's case, scientific fairness won out and she was to be acknowledged for her accomplishments by many honors, including Presidency of the American Association for Cancer Research.
Both of the phenomena encountered by her have become central issues in our own work and will be discussed in the account to follow. A number of possibilities have been raised by these anomalStudies using murine models have indicated that two major types of abnormality must be acquired by a hematopoietic cell ous findings. First, the cells may be like FDC-P1 cells transformed by IL-3 cDNA where autocrine growth factor production if it is to transform from a normal state to a fully-developed leukemic cell.
2 These are: (1) acquisition by some mechanism certainly conferred leukemogenicity but the cells remain factor-dependent in vitro for some reason. Second, the clonoof an abilty to proliferate independently of extrinsic growth factors, so-called autocrine growth stimulation; and (2) acquigenic assays, whether for conventional granulocyte-macrophage colony-forming cells or for blast colonies, may not in sition of an anomaly in differentiation commitment, allowing an abnormally high proportion of the progeny generated to be fact detect the true leukemogenic stem cell. In this context, tests using AML cells in SCID mice suggested that only one parental-like, so-called self-generation. The sequence in which these changes is acquired does not seem to be critical in 250 000 cells is truly clonogenic, as defined by an ability to generate progressive disease in the recipient animals. 10 This as there are models in which leukemic cells emerge with either sequence.
is in sharp contrast to the high frequency of colony-forming cells in CML (100% for purified blast cells) and the highly A third class of acquired abnormality of relevance in leukemia are changes leading to extended lifespans of the cells and variable, but sometimes up to nearly 100%, clonogenicity of AML cells. The in vitro growth pattern of these clonogenic avoidance of apoptosis. The prototype example involves the bcl-2 gene which is characteristically overexpressed in follicucells also raises questions. CML cells generate normal maturing granulocyte-macrophage colonies of unremarkable size.
11 lar lymphoma cells, and whose product is anti-apoptotic in action.
3,4 Anomalies of this type appear not to be directly This is consistent enough with the obvious production of maturing cells by the CML clone in vivo. However, AML cells responsible for leukemic transformation but allow survival of cells with one or other of the above abnormalities, enabling typically exhibit feeble proliferative activity in vitro to form only small clusters 12 which is at odds with their undoubted second abnormalities to occur, thereby completing the required set of changes.
proliferative activity in vivo and maturation in these in vitro clusters is either non-existent or aberrant. Because the required growth factors used in vitro, such as the CSFs, also have a capacity to truncate proliferation by enforced differenAutocrine growth stimulation tiation commitment, 1 one possibility is that extrinsic growth factor stimulation in vitro, the very maneuver required to The simplest models documenting the role of autocrine growth stimulation in leukemogenesis involve the use of the stimulate their proliferation, in fact simultaneously suppresses the extended proliferative capacity of these cells by enforced non-leukemic, but immortalized, murine cell line FDC-P1 -a growth factor-dependent myeloid cell line requiring either differentiation commitment. Alternatively, it has been shown that if autonomous leukemic cells are exposed to agents initi-GM-CSF or IL-3 for survival and proliferation, the cells already possessing an abnormally high capacity for self-generation ating differentiation commitment, the cells then become dependent on stimulation by extrinsic growth factors for sur-(greater than 80%). Insertion and independent expression of cDNA encoding either GM-CSF or IL-3 in these cells promptly vival and proliferation in vitro. 13, 14 These various possibilities remain to be resolved. transforms them to leukemic cells. [5] [6] [7] In most instances, acquisition by the cells of the ability to produce their own growth
In model studies using FDC-P1 cells, it is surprising how often acquisition of autonomy has been based on acquired factor leads to their autonomous growth in vitro. There is an almost universal rule in leukemic biology that autonomous autocrine growth factor production. When FDC-P1 cells are engrafted into irradiated recipients, the injected cells after a growth in vitro equates with an ability to generate transplanted leukemias when the cells are tested in syngeneic recipients.
variable, but often long, delay do transform to leukemic cells 15, 16 and analysis showed most often that this was based However, there are exceptions to this rule. Some FDC-P1 cells transformed by insertion of IL-3 cDNA are leukemogenic but on insertion of an IAP particle upstream of either the GM-CSF or IL-3 gene leading to autocrine production of one or other continue to exhibit absolute dependency in vitro on stimulation by extrinsic IL-3 for survival and proliferation. Congrowth factor. 17 A similar outcome was observed when FDC-P1 cells were injected into transgenic GM-CSF mice having versely, some cell lines derived from fetal liver and transformed to autonomy by infection with v-mpl, the activated excessive circulating levels of GM-CSF. 18 Despite the constant availability of sufficient extrinsic growth factor to ensure the receptor for thrombopoietin, do not behave as leukemic cells proliferation of the FDC-P1 cells, again tranformation virtually on transplantation. While such experiments fall into the controversial grey area between hyperplasia and leukemia, it was was always associated with an acquired ability to produce autocrine GM-CSF or IL-3. Furthermore, when the Moloney obvious that genuine leukemia, as defined by the gold standard of transplantability, was not being achieved. virus was used to transform FDC-P1 cells in vitro, again transformation involved autocrine growth factor production, preThere is no current molecular explanation of the nature of immortalization as exhibited by cells such as FDC-P1. Biologisumably by insertional activation, since this virus lacks an oncogene. 19 cally, however, it is obvious that they have a self-renewal capacity far in excess of the 50% level assumed to be the Even transformation of FDC-P1 cells by the insertion of excess numbers of M-CSF receptors involved the production situation in normal self-maintaining populations like bone marrow stem cells. There could indeed be multiple relevant by the altered cells of M-CSF. 20 A similar maneuver of exposing Ba/F3 cells expressing c-mpl to a chemical carcinogen led abnormalities pre-existing in FDC-P1 cells but the simplest assumption is that a single critical abnormality can lead to the to an autonomous mutant producing thrombopoietin and the method by which one group was able to purify and clone this formation, after cell division, of an excess of parental-type progeny. growth factor. 21 This recurrent pattern might give the impression that leuThis simplified assumption has been validated in studies in which two genes were introduced simultaneously into normal kemic transformation always involves autocrine growth factor production but this is clearly not the case and may reflect a hematopoietic cells -the IL-3 gene and Hox 2.4 gene. The Hox 2.4 product has the ability to enhance self-renewal in curious predisposition of FDC-P1 or Ba/F3 cells for transformation by this method. a subset of primitive hematopoietic cells. 32 Combined expression of both genes led to the immediate transformation From what is now known about the mitotic signaling pathway, cells should equally be able to achieve autocrine growth of affected cells to readily transplantable myeloid leukemic cells, resembling WEHI 3B leukemic cells, 33 the cell line stimulation by two other types of mechanism: (1) production of constitutively activated receptors where mutations in the originally demonstrated to be overexpressing Hox 2.4 and IL-3. 34, 35 receptor chain allow spontaneous dimer formation or activate the chain by other mechanisms; or (2) dysregulated proWhile Hox 2.4 is not recognized as a likely candidate for involvement in human leukemias, there are several candidates duction of an activated, or surrogate molecule in the mitotic signaling cascade. Examples of both are well documented.
that may have an influence on commitment, differentiation induction or self-renewal. Prominent among these is the Mutated dimer-forming receptors for erythropoietin induce autonomous proliferation when transfected into cells, 22 as do aberrant PML-RAR fusion product characteristic of APL with its maturation arrest at the promyelocyte stage. 36 Indeed, conmpl receptors with comparable activating mutations. 23 Similarly, transformation of cells can be achieved using polyoma struction of transgenic PML-RAR mice has been noted to lead to the development of a disease state resembling APL, middle-T antigen, 24 v-abl 25 or bcr-abl, 26 acting as surrogate signaling intermediates. Of particular interest in the context of although the evidence is not yet overwhelming that the cells are unequivocally leukemic. 37 In acute T lymphocyte leukethe present discussion is the fact that the focus-forming viral component of the Friend virus complex is able to induce the mias, aberrant expression of SCL is a common occurrence 38 and, when SCL is overexpressed, it has the capacity to prevent characteristic erythroid proliferation because the viral-encoded gp55 moiety can interact with and activate the erythropodifferentiation commitment in the M1 leukemic cell line normally able to be induced by LIF or OSM. 39 When expressed ietin receptor to achieve ligand-independent signaling, thus relieving the cells of their dependency on extrinsic growth in T lymphocyte cell lines, SCL induced more rapid transformation to lymphoid leukemia 40 and transgenic SCL mice factor stimulation. 27 It remains unclear how commonly these alternative developed an increased incidence of lymphoid leukemia. 41 There is abundant evidence that cooperation between pairs methods are operating in human AML or CML. In the case of CML, the bcr-abl constitutively activated kinase 26 seems likely of oncogenes promotes leukemia development 42 and the temptation is therefore strong to assume that one oncogene is to provide the autocrine proliferative signal component necessary in leukemogenesis. However, no comparable anomalous providing autocrine stimulation while the second interferes with self-renewal. An example that potentially fits this view proliferative signaling product has been noted in the various subtypes of AML and analyses of receptors for a number of would be the cooperation between myc and ras, myc being an essential signaling molecule for cell proliferation while ras, growth factors of likely relevance has so far not detected activating mutations.
at least in C. elegans and yeast, affects differentiation.
Regulator suppression of leukemia Altered self-renewal
When immortalized cells such as FDC-P1 are used, transformAs noted earlier, Charlotte Friend was able to induce terminal erythroid differentiation in erythroleukemic cells using ation was readily accomplished by inducing changes resulting in autocrine growth. This contrasted sharply with the outcome DMSO 43 and subsequently a wide range of chemical agents was observed to have a similar action. Extension of this work of inserting growth factor cDNA into normal hematopoietic cells. When this was done with GM-CSF, 28 G-CSF, 29 IL-3 30 to murine and human myeloid leukemic cell lines identified a similar series of chemical agents able to induce granulocytic and Epo, 31 sustained, presumptively self-stimulated, growth was obtained and animals repopulated by such cells or, more often, monocyte-macrophage differentiation. 44 While these systems are highly artificial they did raise two developed a vast excess of cells exhibiting receptors for the growth factor involved. The invasion of non-hematopoietic points of fundamental importance in leukemia. First, the data indicated that leukemic cells were not irreversibly frozen in organs like lung and liver was sometimes massive and gave the superficial histological appearance of leukemia. However, an undifferentiated state -a fact clearly evident in CML and to a lesser degree in AML. Second, the data raise the possithe cells from such animals did not behave as leukemic cells bility of suppressing a leukemic population by enforced differkemic cells were transfected with a retroviral library containing cDNA from the immortalized cell lines FDC-P1. The genes entiation of the cells to cells that, if not entirely normal, are none the less post-mitotic.
responsibile for the emergence of any resistant clones observed could then be identified in making use of the retroviFew of the many active chemical agents could be regarded as being likely to represent normal physiological regulatory ral tag on the inserted cDNA. The first IL-6-resistant clone analyzed identified the inserted cDNA as encoding a novel promolecules. However, in this context, the recognition of the polyfunctionality of hematopoietic regulators 1 became of tein (SOCS-1) with an SH2 domain and a C-terminal region homologous with the pseudosubstrate regions of JAK kininterest, since one of their actions is differentiation commitment and maturation induction.
ases. 54 Transfection of SOCS-1 into M1 cells conferred on them resistance to differentiation induction by IL-6, LIF or On this basis, tests of GM-CSF and G-CSF [45] [46] [47] clearly showed the ability of these agents, when acting on suitable OSM but did not render the cells unresponsive to differentiation induction by dexamethasone. A data-base search has leukemic cell lines, to suppress clonogenic self-renewal with or without an accompanying maturation. With the subsequent identified 12 other members of this gene family, some of which have now been isolated and found to act in a comparadiscovery of the LIF, IL-6, OSM group of regulators, signaling through a common gp130 receptor chain, regulators became ble manner to SOCS-1. SOCS-1 interferes with phosphorylation and activation of gp130 and STAT3 and appears thereavailable with an exceedingly powerful ability to, at times, totally suppress the commonly used M1 murine leukemic cell fore to have the capacity to modulate and block certain of the signaling cascades normally able to induce differentiation line, with macrophage maturation as an alternative fate of some of the cells. 14, 48 commitment.
54,55 Transcription of the SOCS genes can be induced in leukemic and normal cells by cytokine signaling Indeed, experiments in this laboratory with M1 or WEHI 3B leukemic cell lines expressing a wide range of inserted recepbut the induction patterns of the different members of this family differ, raising the possibility of quite subtle modulation of tors such as those for human GM-CSF or murine M-CSF, G-CSF, TPO or leptin have shown that the relevant ligand can signaling pathways in response to cytokine stimulation. These studies have identified a new class of cytoplasmic then actively suppress the leukemic cells. This indicates that this type of cellular response is quite promiscuous, at least in modulators of signaling. While it is too early to know whether any of the family are responsible for the unresponsiveness of terms of the initial signaling events in the cascade activated when ligand binds to its receptor. Analysis of M1 and WEHIhuman myeloid leukemic populations or for the differentiation anomalies in the myelodysplasias, it is reasonable to expect 3B cells with inserted mutated receptor chains has identified specific regions of the receptor necessary to initiate this differthat they may well play a role in these disease states. entiation commitment -regions that are separate from the Box 1-Box 2 juxtamembrane regions necessary for mitotic signaling. 49 
Concluding comments
These studies have raised the intriguing possibility that regulators might be useful clinical agents to suppress a myeloid While the molecular control of hematopoiesis is becoming leukemic population, despite the fact that receptor signaling well understood, it is proving difficult to relate this information would also potentially stimulate the proliferation of such cells.
to the clearly emerging gene abnormalities in particular types Clinical experience with the use of GM-CSF or G-CSF in of human leukemia. Connections must exist and simplified myeloid leukemic patients has documented their cycle-activmurine models document the general nature of such connecating action on leukemic cells 50, 51 but has yet to document tions. Nevertheless, comparable models cannot yet be conan induction of maturation in any way approaching that structed for any one type of human leukemia and until this is achievable by retinoic acid in the treatment of APL patients. achieved, it is not likely that advances will be possible in the There are several obvious problems in this approach. Analymanagement of leukemia that would represent a significant sis of AML populations has shown, for example, that many improvement over the present use of highly toxic and unselecpopulations express G-CSF receptors but autoradiographic tive chemotherapy. studies have shown that often not all of the leukemic blast Without being in a position to recognize the full implicells in the population express such receptors and could not cations of her early observations, Charlotte Friend pursued her therefore be expected to be responsive to G-CSF inhibition. 52 studies with care and enthusiasm. Her work was the forerun-APL populations were exceptional in this regard in uniformly ner of much of the current work on the nature and control of expressing high numbers of G-CSF receptors. 53 More serileukemia and she deserves our respect and acknowledgement ously, most leukemic populations and cell lines are quite for her pioneering work. unresponsive to cytokine-induced differentiation.
This latter problem has prompted studies in this laboratory to establish the basis for the appearance of differentiationReferences resistant mutants in the normally highly responsive M1 leukemic cell line, using IL-6 as a powerful inducing agent. Initial In an attempt to identify genes conferring dominant resist-5 Lang RA, Metcalf D, Gough NM, Dunn AR, Gonda TJ. Expression of a hemopoietic growth factor cDNA in a factor-dependent cell ance to IL-6, a different strategy was adopted. In this, M1 leu-
